59 results
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
) the nature of any substantive amendment to our Code of Business Conduct and Ethics that applies to our principal executive officer, principal financial officer … , principal accounting officer or controller or persons performing similar functions and (2) the nature of any waiver, including an implicit waiver
10-K
2023 FY
EX-10.23
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
such changes may have under Section 6 of this Agreement). This “at-will” nature of Executive’s employment shall remain unchanged during Executive’s tenure
10-K
2023 FY
EX-10.22
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
discretion of the Company (subject to any ramification such changes may have under Section 6 of this Agreement). This “at-will” nature of Executive’s
10-K
zv035w4mggx0 bi1nu
7 Mar 24
Annual report
4:05pm
10-Q
9ywcgi
1 Nov 23
Quarterly report
4:05pm
S-8
EX-99.1
i5ndj
19 Sep 23
Registration of securities for employees
9:57pm
8-K
EX-3.2
rg8bdp7x
19 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
424B4
t1w3rultpl6ojw
18 Sep 23
Prospectus supplement with pricing info
4:12pm
S-1/A
ks94tbzto b9t8myad4z
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
EX-10.13
xhbzg
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
EX-1.1
ytah0vw6qckp51 in64v
11 Sep 23
IPO registration (amended)
6:07am
S-1
EX-10.17
byhbz76ch 3n
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.4
4sca63b
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.11
070mu7un d3
25 Aug 23
IPO registration
5:03pm
S-1
EX-3.4
4g5rl10
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.2
xpg161b47c
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.10
fiygr8bx98wf1o5
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.16
q70hg1
25 Aug 23
IPO registration
5:03pm